相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Manmeet S. Ahluwalia et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
Single-cell spatial immune landscapes of primary and metastatic brain tumours
Elham Karimi et al.
NATURE (2023)
Therapy with oncolytic viruses: progress and challenges
Sophia Z. Shalhout et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy
Yoshihiro Otani et al.
CLINICAL CANCER RESEARCH (2022)
The CD70-CD27 axis in oncology: the new kids on the block
Tal Flieswasser et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial
E. Antonio Chiocca et al.
NEURO-ONCOLOGY (2022)
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
Nourhan Abdelfattah et al.
NATURE COMMUNICATIONS (2022)
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10
Vidhya M. Ravi et al.
NATURE COMMUNICATIONS (2022)
Engineered cells as glioblastoma therapeutics
Aparna Ramanathan et al.
CANCER GENE THERAPY (2022)
A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy
Niaz Muhammad et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Michael Lim et al.
NEURO-ONCOLOGY (2022)
Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities
Johannes K. Andersen et al.
CANCERS (2022)
Intratumoral oncolytic herpes virus G47 increment for residual or recurrent glioblastoma: a phase 2 trial
Tomoki Todo et al.
NATURE MEDICINE (2022)
Integrative multi-omics approach to targeted therapy for glioblastoma
Lynnette Koh et al.
PHARMACOLOGICAL RESEARCH (2022)
New mechanistic insights of the pathogenicity of high-risk cytomegalovirus (CMV) strains derived from breast cancer: Hope for new cancer therapy options
Cecilia Soderberg-Nauclera
EBIOMEDICINE (2022)
Early myeloid-derived suppressor cells accelerate epithelial-mesenchymal transition by downregulating ARID1A in luminal A breast cancer
Guidong Chen et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma
Qu-Jing Gai et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Immune suppression in gliomas
Matthew M. Grabowski et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Cytotoxic CD8+T cells in cancer and cancer immunotherapy
Hans Raskov et al.
BRITISH JOURNAL OF CANCER (2021)
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor
Kelly M. Hotchkiss et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Lakshmi Nayak et al.
CLINICAL CANCER RESEARCH (2021)
Antitumor CD8 T cell responses in glioma patients are effectively suppressed by T follicular regulatory cells
Lenian Lu et al.
EXPERIMENTAL CELL RESEARCH (2021)
The regulation of macrophage polarization by hypoxia-PADI4 coordination in Rheumatoid arthritis
Yu Cheng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review
Maham Farshidpour et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Immune checkpoint inhibitors in GBM
Eudocia Q. Lee
JOURNAL OF NEURO-ONCOLOGY (2021)
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Nathan D. Mathewson et al.
CELL (2021)
Diffuse Glioma Heterogeneity and Its Therapeutic Implications
James G. Nicholson et al.
CANCER DISCOVERY (2021)
Oncolytic virus in gliomas: a review of human clinical investigations
A. B. Carpenter et al.
ANNALS OF ONCOLOGY (2021)
Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
Angeliki Datsi et al.
FRONTIERS IN IMMUNOLOGY (2021)
MDSC: Markers, development, states, and unaddressed complexity
Samarth Hegde et al.
IMMUNITY (2021)
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Michael Platten et al.
NATURE (2021)
Chimeric Antigen Receptor T Cells for Glioblastoma Current Concepts, Challenges, and Future Perspectives
Philipp Karschnia et al.
NEUROLOGY (2021)
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
Alexander Spira et al.
TARGETED ONCOLOGY (2021)
Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker
Andrew X. Chen et al.
GENOME MEDICINE (2021)
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
Joseph S. Durgin et al.
FRONTIERS IN ONCOLOGY (2021)
New insights into M1/M2 macrophages: key modulators in cancer progression
Jiuyang Liu et al.
CANCER CELL INTERNATIONAL (2021)
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy
Simon Eschweiler et al.
NATURE IMMUNOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy
Rikke Sick Andersen et al.
CANCERS (2021)
Single-Cell Omics in Dissecting Immune Microenvironment of Malignant Gliomas-Challenges and Perspectives
Bozena Kaminska et al.
CELLS (2021)
Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
Ni Tong et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide
Jing Li et al.
SCIENTIFIC REPORTS (2021)
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells
Hila Shaim et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Single-cell proteomic and transcriptomic analysis of macrophage heterogeneity using SCoPE2
Harrison Specht et al.
GENOME BIOLOGY (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
John de Groot et al.
NEURO-ONCOLOGY (2020)
MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/beta-catenin signaling pathway
Wei Yang et al.
ONCOGENE (2020)
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
Giulia Golinelli et al.
CANCER GENE THERAPY (2020)
Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients
Qian-Ting Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
David A. Reardon et al.
CLINICAL CANCER RESEARCH (2020)
Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
Alexandre Teixeira Vessoni et al.
ONCOGENE (2020)
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol
Nicholas F. Brown et al.
BMC CANCER (2020)
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
Sue Han et al.
BRITISH JOURNAL OF CANCER (2020)
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma
Sascha Marx et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Defne Bayik et al.
CANCER DISCOVERY (2020)
Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils
Anm Nazmul H. Khan et al.
CANCER IMMUNOLOGY RESEARCH (2020)
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Yajing Mi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
Weilun Fu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Arginase-1+Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression
Juliana H. Azambuja et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression
Tyler J. Alban et al.
FRONTIERS IN IMMUNOLOGY (2020)
Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
E. Antonio Chiocca et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
Rebekka Weber et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function
Shih-Ying Wu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Granulocytic Myeloid-Derived Suppressor Cell Exosomal Prostaglandin E2 Ameliorates Collagen-Induced Arthritis by Enhancing IL-10+ B Cells
Xinyu Wu et al.
FRONTIERS IN IMMUNOLOGY (2020)
MIF-Dependent Control of Tumor Immunity
Jordan T. Noe et al.
FRONTIERS IN IMMUNOLOGY (2020)
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
Craig A. Land et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases
Yizhuo Wang et al.
CELL DEATH & DISEASE (2020)
T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma
Yang Zhang et al.
ONCOIMMUNOLOGY (2020)
B cell and B cell-related pathways for novel cancer treatments
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2019)
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
William Tomaszewski et al.
CLINICAL CANCER RESEARCH (2019)
Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis
Harald Krenzlin et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients
Denis Migliorini et al.
NEURO-ONCOLOGY (2019)
Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro
Yoshitaka Tanaka et al.
PLOS ONE (2019)
M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Youhan Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Genetic and molecular epidemiology of adult diffuse glioma
Annette M. Molinaro et al.
NATURE REVIEWS NEUROLOGY (2019)
Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
Karolina Okla et al.
FRONTIERS IN IMMUNOLOGY (2019)
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
Xin Tang et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity
Aurobind Vidyarthi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
ATIM-28. PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEWLY DIAGNOSED GBM PATIENTS
Daniela Bota et al.
NEURO-ONCOLOGY (2019)
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas
Pia S. Zeiner et al.
BRAIN PATHOLOGY (2019)
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
Christopher Groth et al.
BRITISH JOURNAL OF CANCER (2019)
Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a/Hbp1 and microRNA-92a/Prkar1a pathways
Xiaofan Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
EGFRvIII: An Oncogene with Ambiguous Role
Adrianna Rutkowska et al.
JOURNAL OF ONCOLOGY (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
CD70, a novel target of CAR T-cell therapy for gliomas
Linchun Jin et al.
NEURO-ONCOLOGY (2018)
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
Surabhi Ranjan et al.
BMC CANCER (2018)
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets
Stephan Lang et al.
CLINICAL CANCER RESEARCH (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment
Wouter B. L. van den Bossche et al.
NEURO-ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
Zhenyi An et al.
ONCOGENE (2018)
FHL2 interacts with EGFR to promote glioblastoma growth
Lili Sun et al.
ONCOGENE (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
NKG2D: A Master Regulator of Immune Cell Responsiveness
Felix M. Wensveen et al.
FRONTIERS IN IMMUNOLOGY (2018)
A randomized, multicenter phase 2 study of DSP-7888 dosing emulsion in combination with bevacizumab (Bev) versus Bev alone in patients with recurrent or progressive glioblastoma.
John Frederick De Groot et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Pakawat Chongsathidkiet et al.
NATURE MEDICINE (2018)
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
Vassilis Genoud et al.
ONCOIMMUNOLOGY (2018)
Harnessing the immune system in glioblastoma
Nicholas F. Brown et al.
BRITISH JOURNAL OF CANCER (2018)
TIM-3, a promising target for cancer immunotherapy
Yayi He et al.
ONCOTARGETS AND THERAPY (2018)
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis
Tyler J. Alban et al.
JCI INSIGHT (2018)
Microglia and macrophages in brain homeostasis and disease
Qingyun Li et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiss et al.
CANCER RESEARCH (2018)
EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
Stefanie Keller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Song Xue et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
Effective combinatorial immunotherapy for castration-resistant prostate cancer
Xin Lu et al.
NATURE (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
Jennifer P. Newman et al.
NATURE COMMUNICATIONS (2017)
Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities
Simon Memmel et al.
ONCOTARGET (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
CD163+ CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma
Keigo Kubota et al.
SCIENTIFIC REPORTS (2017)
The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis
Song Xue et al.
SCIENTIFIC REPORTS (2017)
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival
Lijie Zhai et al.
CLINICAL CANCER RESEARCH (2017)
The regulation of immune tolerance by FOXP3
Ling Lu et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy
Orin Bloch et al.
CLINICAL CANCER RESEARCH (2017)
Harnessing macrophage plasticity for tissue regeneration
Tim D. Smith et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Kristen A. Batich et al.
CLINICAL CANCER RESEARCH (2017)
Ontogeny and homeostasis of CNS myeloid cells
Marco Prinz et al.
NATURE IMMUNOLOGY (2017)
Microglial M1/M2 polarization and metabolic states
Ruben Orihuela et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
Daniel Dubinski et al.
NEURO-ONCOLOGY (2016)
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation
Kavitha Yaddanapudi et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
Sabrina Genssler et al.
ONCOIMMUNOLOGY (2016)
EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation
Yuho Hamaoka et al.
CELLULAR SIGNALLING (2016)
Ipilimumab and Bevacizumab in Glioblastoma
T. Carter et al.
CLINICAL ONCOLOGY (2016)
Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function
Paul R. Gielen et al.
NEURO-ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression
A. Ellert-Miklaszewska et al.
ONCOGENE (2016)
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Balint Otvos et al.
STEM CELLS (2016)
IL-13 receptor α2 stimulates human glioma cell growth and metastasis through the Src/PI3K/Akt/mTOR signaling pathway
Ming Tu et al.
TUMOR BIOLOGY (2016)
Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR
Xiaofan Guo et al.
ONCOTARGET (2016)
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Robert L. Bowman et al.
CELL REPORTS (2016)
DSP-7888, a Novel Cocktail Design of WT1 Peptide Vaccine, and Its Combinational Immunotherapy with Immune Checkpoint-Blocking Antibody Against PD-1
Masashi Goto et al.
BLOOD (2016)
Combinatorial targeting of tumor-associated macrophages/ microglia and radiotherapy in gliomas
Leila Akkari et al.
CANCER RESEARCH (2015)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
Regulatory B Cells: Origin, Phenotype, and Function
Elizabeth C. Rosser et al.
IMMUNITY (2015)
Macrophage migration inhibitory factor involvement in breast cancer
Vincent Richard et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cytomegalovirus and glioblastoma; controversies and opportunities
Sean E. Lawler
JOURNAL OF NEURO-ONCOLOGY (2015)
Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes
Baisakhi Raychaudhuri et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue
Paul R. Gielen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
James Schuster et al.
NEURO-ONCOLOGY (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation?
Eleonora Derlindati et al.
PLoS One (2015)
Glucose-regulated protein 94 is a novel glioma biomarker and promotes the aggressiveness of glioma via Wnt/β-catenin signaling pathway
Tieyi Hu et al.
TUMOR BIOLOGY (2015)
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
Douglas G. Walker et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Tim-3 and Tim-4 as the potential targets for antitumor therapy
Lin Cheng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Molecular heterogeneity in glioblastoma: potential clinical implications
Nicole Renee Parker et al.
FRONTIERS IN ONCOLOGY (2015)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Jia Xue et al.
IMMUNITY (2014)
Transcriptomic analysis of mononuclear phagocyte differentiation and activation
David A. Hume et al.
IMMUNOLOGICAL REVIEWS (2014)
Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme
Adam M. Swartz et al.
IMMUNOTHERAPY (2014)
Glioma cell-derived placental growth factor induces regulatory B cells
Song Han et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
Wilms tumor 1 gene, CD97, and the emerging biogenetic profile of glioblastoma
Aravind Somasundaram et al.
NEUROSURGICAL FOCUS (2014)
Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
Zineb Belcaid et al.
PLOS ONE (2014)
Current Vaccine Trials in Glioblastoma: A Review
LindaW. Xu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer
Leona Mawhinney et al.
MOLECULAR MEDICINE (2014)
GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α
Gary Kohanbash et al.
CANCER RESEARCH (2013)
Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia
Aleksandra Ellert-Miklaszewska et al.
GLIA (2013)
Prognostic significance of CD147 in patients with glioblastoma
Min Yang et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
Christine E. Brown et al.
PLOS ONE (2013)
A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors
Emilia Mira et al.
ONCOTARGET (2013)
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
Lishomwa C. Ndhlovu et al.
BLOOD (2012)
Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor-Modified T Cells
Seogkyoung Kong et al.
CLINICAL CANCER RESEARCH (2012)
IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
Derek A. Wainwright et al.
CLINICAL CANCER RESEARCH (2012)
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
R. Bonavia et al.
ONCOGENE (2012)
TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
Xin Gao et al.
PLOS ONE (2012)
Activating and inhibitory receptors of natural killer cells
Hollie J. Pegram et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma
Janna Paulsson et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
In-vitro effects of the tyrosine kinase inhibitor imatinib on glioblastoma cell proliferation
E. Ranza et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma
Omar Eton et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8(+) T cells glioma patients
Courtney A. Crane et al.
NEURO-ONCOLOGY (2010)
Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
Philip C. De Witt Hamer
NEURO-ONCOLOGY (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Differential Effect of Imatinib and Synergism of Combination Treatment with Chemotherapeutic Agents in Malignant Glioma Cells
Huan Ren et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
Joannes F. M. Jacobs et al.
NEURO-ONCOLOGY (2009)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma
Jean-Francois Mineo et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4(+) T cell compartment without affecting regulatory T-cell function
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2007)
Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression
Kazuki Nabeshima et al.
PATHOLOGY INTERNATIONAL (2006)
Physiologic and metabolic magnetic resonance imaging in gliomas
Y Cao et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
T Dohi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms
A Chakravarti et al.
ONCOGENE (2004)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
Y Oji et al.
CANCER SCIENCE (2004)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
K Takeda et al.
NATURE MEDICINE (2001)
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens
HD Menssen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Determination of intracranial tumor volumes in a rodent brain using magnetic resonance imaging, Evans Blue, and histology: A comparative study
SS Prabhu et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2000)